Update, Bayer clears a key litigation milestone, shares stay in focus
28.06.2026 - 09:09:15 | ad-hoc-news.de
By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-28, 07:08.
Bayer (DE000BAY0017) stays in the DAX spotlight on Sunday after MarketScreener listed several June 26 analyst notes tied to the Roundup litigation backdrop. Reuters-linked market commentary on June 26 also pointed to BofA, DZ Bank, UBS and Mwb updates on the name.
Analyst notes stay active
MarketScreener’s Bayer quote page showed June 26 items including “Bayer Kept at Buy as BofA Notes 'Big Win' for Glyphosate Litigation” and “UBS reiterates its Buy rating.” The same page also listed Mwb lifting its price target after the US Supreme Court win in the Roundup dispute.
Finanzen100’s Bayer page identified the stock as BAYN on Xetra and placed it inside the DAX basket, with Germany as the home market. That gives the shares a clear local trading anchor for German investors.
Monday's calendar matters
Monday’s calendar is the relevant next step for the stock, with Bayer already carrying a visible earnings-history trail. MarketScreener’s company page references a Bayer Aktiengesellschaft Q1 2026 earnings call on May 12, 2026, which remains the latest dated company event in the search set.
The analyst picture is mixed but concrete. On the same MarketScreener page, DZ Bank is shown as remaining at Buy, while AlphaValue/Baader Europe is shown downgrading Bayer to Reduce and lifting its fair value.
All news and analysis on Bayer shares
Use this hub for the latest coverage, analyst notes and company updates around Bayer on Xetra.
Glyphosate drives the story
Bayer’s core business mix still centers on pharmaceuticals, crop science and consumer health, but the market conversation is still heavily shaped by glyphosate litigation. That is the backdrop behind the June 26 analyst updates highlighted on MarketScreener.
Xetra price check
The Bayer shares (DE000BAY0017) trade on Xetra at 47.00 euros, according to the quoted price shown on Finanzen100, with the page dated 2026-06-26. The same source also lists the symbol BAYN and the DAX as the relevant index reference.
Key data on Bayer shares
- Company: Bayer Aktiengesellschaft
- ISIN: DE000BAY0017
- Ticker: BAYN
- Trading venue: Xetra
- Price (as of 2026-06-26, 00:00): 47.00 euros
- Sector / industry: Pharmaceuticals
- Index membership: DAX
Disclaimer: This article is for information only and does not constitute investment advice.
